| Outcome Measures: |
Primary: Change in Glycated haemoglobin A1c (HbA1c), Measured as percentage (%)-points., From baseline (week 0) to End of Study visit (V3) (week 34-44) | Secondary: Relative change in body weight, Measured in percentage (%)., From baseline (week 0) to End of Study visit (V3) (week 34-44)|Absolute change in body weight, Measured in kilogram (kg)., From baseline (week 0) to End of Study visit (V3) (week 34-44)|Glycated haemoglobin A1c (HbA1c) less than (<) 7%, Measured as Yes or No., At End of Study visit (V3) (week 34-44)|HbA1c reduction greater than or equal to (>=) 1%-points and body weight reduction of greater than or equal to (>=) 5%, Measured as Yes or No., From baseline (week 0) to End of Study visit (V3) (week 34-44)|HbA1c reduction greater than or equal to (>=) 1%-points and body weight reduction of greater than or equal to (>=) 3%, Measured as Yes or No., From baseline (week 0) to End of Study visit (V3) (week 34-44)
|
